Cargando…
Comparing CABG and PCI across the globe based on current regional registry evidence
There is an ongoing debate whether coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) provide better results for the treatment of coronary artery disease (CAD). We aimed to evaluate the impact of CABG or PCI on long-term survival based on local reports from different...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780238/ https://www.ncbi.nlm.nih.gov/pubmed/36550130 http://dx.doi.org/10.1038/s41598-022-25853-4 |
_version_ | 1784856792441815040 |
---|---|
author | Caldonazo, Tulio Kirov, Hristo Riedel, Leoni Lu Gaudino, Mario Doenst, Torsten |
author_facet | Caldonazo, Tulio Kirov, Hristo Riedel, Leoni Lu Gaudino, Mario Doenst, Torsten |
author_sort | Caldonazo, Tulio |
collection | PubMed |
description | There is an ongoing debate whether coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) provide better results for the treatment of coronary artery disease (CAD). We aimed to evaluate the impact of CABG or PCI on long-term survival based on local reports from different regions in the world. We systematically searched MEDLINE selecting studies that compared outcomes for CABG or PCI as a treatment for CAD in the last 10 years. Reports without all-cause mortality, multi-national cohorts, hybrid revascularization populations were excluded. Qualifying studies were statistically compared, and their geographic location visualized on a world map. From 5126 studies, one randomized and twenty-two observational studies (19 risk-adjusted) met the inclusion criteria. The mean follow-up was 4.7 ± 7 years and 18 different countries were included. In 17 studies, CABG was associated with better survival during follow-up, six studies showed no significant difference, and no study favored PCI. Periprocedural mortality was not different in seven, lower with PCI in one, lower with CABG in three and not reported in 12 studies. In regional registry-type comparisons, CABG is associated with better long-term survival compared to PCI in most regions of the world without evidence for higher periprocedural mortality. |
format | Online Article Text |
id | pubmed-9780238 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-97802382022-12-24 Comparing CABG and PCI across the globe based on current regional registry evidence Caldonazo, Tulio Kirov, Hristo Riedel, Leoni Lu Gaudino, Mario Doenst, Torsten Sci Rep Article There is an ongoing debate whether coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) provide better results for the treatment of coronary artery disease (CAD). We aimed to evaluate the impact of CABG or PCI on long-term survival based on local reports from different regions in the world. We systematically searched MEDLINE selecting studies that compared outcomes for CABG or PCI as a treatment for CAD in the last 10 years. Reports without all-cause mortality, multi-national cohorts, hybrid revascularization populations were excluded. Qualifying studies were statistically compared, and their geographic location visualized on a world map. From 5126 studies, one randomized and twenty-two observational studies (19 risk-adjusted) met the inclusion criteria. The mean follow-up was 4.7 ± 7 years and 18 different countries were included. In 17 studies, CABG was associated with better survival during follow-up, six studies showed no significant difference, and no study favored PCI. Periprocedural mortality was not different in seven, lower with PCI in one, lower with CABG in three and not reported in 12 studies. In regional registry-type comparisons, CABG is associated with better long-term survival compared to PCI in most regions of the world without evidence for higher periprocedural mortality. Nature Publishing Group UK 2022-12-22 /pmc/articles/PMC9780238/ /pubmed/36550130 http://dx.doi.org/10.1038/s41598-022-25853-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Caldonazo, Tulio Kirov, Hristo Riedel, Leoni Lu Gaudino, Mario Doenst, Torsten Comparing CABG and PCI across the globe based on current regional registry evidence |
title | Comparing CABG and PCI across the globe based on current regional registry evidence |
title_full | Comparing CABG and PCI across the globe based on current regional registry evidence |
title_fullStr | Comparing CABG and PCI across the globe based on current regional registry evidence |
title_full_unstemmed | Comparing CABG and PCI across the globe based on current regional registry evidence |
title_short | Comparing CABG and PCI across the globe based on current regional registry evidence |
title_sort | comparing cabg and pci across the globe based on current regional registry evidence |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780238/ https://www.ncbi.nlm.nih.gov/pubmed/36550130 http://dx.doi.org/10.1038/s41598-022-25853-4 |
work_keys_str_mv | AT caldonazotulio comparingcabgandpciacrosstheglobebasedoncurrentregionalregistryevidence AT kirovhristo comparingcabgandpciacrosstheglobebasedoncurrentregionalregistryevidence AT riedelleonilu comparingcabgandpciacrosstheglobebasedoncurrentregionalregistryevidence AT gaudinomario comparingcabgandpciacrosstheglobebasedoncurrentregionalregistryevidence AT doensttorsten comparingcabgandpciacrosstheglobebasedoncurrentregionalregistryevidence |